Stocks and Investing
by (remove) : Kelly Shi
RSS • JSON • XML • CSV
Stocks and Investing
by (remove) : Kelly Shi
RSS • JSON • XML • CSV

Kelly Shi Maintained (ASND) at Strong Buy with Increased Target to $196 on, Aug 13th, 2024


Published on 2024-10-28 13:37:09 - WOPRAI, Kelly Shi
  Print publication without navigation


Kelly Shi of Jefferies, Maintained "Ascendis Pharma A/S" (ASND) at Strong Buy with Increased Target from $174 to $196 on, Aug 13th, 2024.

Kelly has made no other calls on ASND in the last 4 months.



There are 6 other peers that have a rating on ASND. Out of the 6 peers that are also analyzing ASND, 1 agrees with Kelly's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Vikram Purohit of "Morgan Stanley" Maintained at Hold with Increased Target to $140 on, Thursday, May 16th, 2024


These are the ratings of the 5 analyists that currently disagree with Kelly

  • Yaron Werber of "TD Cowen" Upgraded from Hold to Strong Buy and Increased Target to $175 on, Tuesday, June 25th, 2024
  • Alex Thompson of "Stifel" Initiated at Strong Buy and Held Target at $200 on, Friday, May 31st, 2024
  • Li Watsek of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $173 on, Wednesday, May 15th, 2024
  • Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $262 on, Friday, May 3rd, 2024
  • Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $170 on, Friday, May 3rd, 2024
Contributing Sources